Champions Oncology Inc share price logo

Champions Oncology Inc Share Price

NASDAQ: CSBR

Small Cap

$5.65

-0.14

(-2.42%)

as on

Champions Oncology Inc Stock Performance

as on March 28, 2026 at 6:55 am IST

  • Day's High

    $5.65
    $5.90

    4.42%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $5.50
    $9.63
    downward going graph

    2.65%

    Downside

    70.44%

    Upside

    downward going graph

Champions Oncology Inc share price movements today

Previous Close
$5.79
Open
$5.82
Volume
195.8K
Day's Low - High
$5.65 - $5.90
52 Week Low - High
$5.50 - $9.63

Champions Oncology Inc Historical Returns

1 Month Return
-5.44 %
3 Month Return
-12.38 %
1 Year Return
-36.99 %
3 Year Return
+ 40 %
5 Year Return
-50.09 %

Champions Oncology Inc Stock Fundamentals & Key Indicators

Check Champions Oncology Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$79.7M

EPS (TTM)

0.12

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.61%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-772.0K

Revenue (TTM)

57.9M

Profit Margin

-4.04%

Return On Equity TTM

-47.59%

Champions Oncology Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Champions Oncology Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Champions Oncology Inc image
Champions Oncology Inc
SELL$79.7M-50.09%NA-4.04%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.1B134.86%136.798.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$110.0B103.33%28.2532.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.5BNA115.055.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.0B56.74%17.7931.41%

Stock Returns calculator for Champions Oncology Inc Stock including INR - Dollar returns

The Champions Oncology Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Champions Oncology Inc investment value today

Current value as on today

₹68,675

Returns

-₹31,325

(-31.33%)

Returns from Champions Oncology Inc Stock

-₹37,980 (-37.98%)

Dollar Impact

₹6,655 (+6.65%)

Analyst Recommendation on Champions Oncology Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Champions Oncology Inc. Average target price of $12

Champions Oncology Inc Share Price Target

Get share price movements and forecasts by analysts on Champions Oncology Inc.

What analysts predicted

52.92%UPSIDE

Target Price

$12

Current Price

$5.65

Analyzed by

6 Analysts

Target

$12.00

Champions Oncology Inc target price $12, a slight upside of 52.92% compared to current price of $5.65. According to 6 analysts rating.

Champions Oncology Inc Stock’s Investor Sentiment and Interest

Search interest for Champions Oncology Inc Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-10% versus previous 30 day period

Champions Oncology Inc Quarterly Profit & Loss

All numbers in Millions USD

Oct 2023
Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Total Revenue
11
12
14
14
13
17
12
13
15
16
Gross Profit
4
4
6
6
5
10
4
5
7
7
Operating Income
-1
-2
0
1
0
4
-1
0
0
0
EBITDA
-1
-2
0
1
1
4
-1
0
0
0
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-2
0
1
0
4
-1
0
0
0
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-2
-2
0
1
0
4
-1
0
0
0
Net Profit Margin
-17.90%
-21.05%
-0.78%
9.34%
5.40%
26.38%
-14.84%
-3.12%
1.99%
-1.68%

Champions Oncology Inc Annual Profit & Loss

All numbers in Millions USD

Apr 2016
Apr 2017
Apr 2018
Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Total Revenue
11
15
20
27
32
41
49
53
50
56
Gross Profit
2
5
9
12
15
19
25
24
20
26
Operating Income
-10
-6
-1
0
-1
0
0
-4
-6
4
EBITDA
-10
-6
-1
0
0
2
2
-2
-5
6
Interest Expense
-
-
-
0
0
0
0
-
0
0
Depreciation
-
0
0
0
0
1
1
2
1
1
Income Before Tax
-10
-6
-1
0
-1
0
0
-5
-7
4
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-10
-6
-1
0
-2
0
0
-5
-7
4
Net Profit Margin
-93.42%
-44.67%
-7.29%
0.47%
-6.52%
0.88%
1.12%
-9.90%
-14.51%
8.26%

Champions Oncology Inc Quarterly Cash Flow

All numbers in Millions USD

Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Net Income
-2
0
1
0
4
-1
0
0
0
Operating Cash Flow
0
-1
0
0
0
6
0
-1
-1
Investing Cash Flow
0
0
-
0
0
0
0
0
0
Financing Cash Flow
0
0
0
0
-
0
0
0
0
Change in Cash
-1
-1
0
0
0
6
0
-1
-1

Champions Oncology Inc Annual Cash Flow

All numbers in Millions USD

Apr 2017
Apr 2018
Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Net Income
-6
-1
0
-1
0
0
-5
-7
4
Operating Cash Flow
-2
-1
1
2
-1
6
3
-6
7
Investing Cash Flow
0
-1
0
-2
-3
-2
-2
0
0
Financing Cash Flow
4
0
1
4
1
0
0
0
0
Change in Cash
0
-2
2
5
-3
4
1
-7
7

Global Institutional Holdings in Champions Oncology Inc

Funds
Holdings
State Street Corp
0.19%
Mesirow Fin Investmt Mgmt Intl Equity
0.07%
Mink Brook Asset Management LLC
0.58%
Acadian Asset Management LLC
0.26%
Hillsdale Investment Management Inc.
0.18%
See all

Insights on Champions Oncology Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 12.35M → 16.55M (in $), with an average increase of 9.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 18.2% return, outperforming this stock by 55.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 62.6% return, outperforming this stock by 22.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, CSBR stock has moved down by -37.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 299.0K → -279.0K (in $), with an average decrease of 193.3% per quarter

About Champions Oncology Inc

champions oncology, inc. is engaged in the development of advanced technology solutions to personalize the development and use of oncology drugs. champions tumorgraft™ technology platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments, or tumorgrafts, in a manner that preserves the biological characteristics of the original human tumor. champions believes that these tumorgrafts, unlike cell line derived xenografts used in tradition testing, closely reflect human cancer biology and their response to drugs is predictive of clinical outcomes in cancer patients. the company offers personalized tumorgraft development, drug studies and genome sequencing as part of its personalized oncology solutions ("pos") whereby physicians can evaluate the effects of cancer drugs on their patients' tumorgrafts and understand the genetic make-up of their patient's tumor enabling them
OrganisationChampions Oncology Inc
HeadquartersOne University Plaza, Hackensack, NJ, United States, 07601
IndustryHealth Technology
CEOMr. Robert Brainin
E-voting on sharesClick here to vote

Key Management of Champions Oncology Inc

Name

Title

Dr. Ronnie Morris M.D.

Executive Chair

Mr. Robert Brainin

CEO & Director

Mr. David Barry Miller M.B.A.

Chief Financial Officer

Dr. Maria Mancini Ph.D.

Chief Operating Officer

Dr. Marianna Zipeto Ph.D.

Executive Vice President of Growth, Strategy & Enablement

FAQs

What is Champions Oncology Inc share price today?

Champions Oncology Inc share price today is $5.65 as on at the close of the market. Champions Oncology Inc share today touched a day high of $5.9 and a low of $5.65.

What is the 52 week high and 52 week low for Champions Oncology Inc share?

Champions Oncology Inc share touched a 52 week high of $9.63 on and a 52 week low of $5.5 on . Champions Oncology Inc stock price today i.e. is closed at $5.65,which is 41.33% down from its 52 week high and 2.73% up from its 52 week low.

What is Champions Oncology Inc's market capitalisation today?

Champions Oncology Inc market capitalisation is $0.00T as on .

How to invest in Champions Oncology Inc Stock (CSBR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Champions Oncology Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Champions Oncology Inc Shares that will get you 0.2655 shares as per Champions Oncology Inc share price of $5.65 per share as on March 28, 2026 at 1:25 am IST.

What is the minimum amount required to buy Champions Oncology Inc Stock (CSBR) from India?

Indian investors can start investing in Champions Oncology Inc (CSBR) shares with as little as ₹94.63 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.30 in Champions Oncology Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Champions Oncology Inc share’s latest price of $5.65 as on March 28, 2026 at 1:25 am IST, you will get 1.7699 shares of Champions Oncology Inc. Learn more about fractional shares .

What are the returns that Champions Oncology Inc has given to Indian investors in the last 5 years?

Champions Oncology Inc stock has given -50.09% share price returns and 29.6% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?